Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Mulder

Showing results (91-100 of 116) with videos related to

Pageof 12
Sort By:
Scientific Reports|December 1, 2018
Publisher Correction: MicroRNAs regulating superoxide dismutase 2 are new circulating biomarkers of heart failureEmilie Dubois-Deruy, Marie Cuvelliez, Jan Fiedler, et al.
Scientific Reports|November 9, 2017
MicroRNAs regulating superoxide dismutase 2 are new circulating biomarkers of heart failureEmilie Dubois-Deruy, Marie Cuvelliez, Jan Fiedler, et al.
Scientific Reports|January 29, 2021
Antifibrotic effect of novel neutrophil gelatinase-associated lipocalin inhibitors in cardiac and renal disease modelsBenjamin Bonnard, Ernesto Martínez-Martínez, Amaya Fernández-Celis, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 1, 2014
Gene deletion of protein tyrosine phosphatase 1B protects against sepsis-induced cardiovascular dysfunction and mortalityDavid Coquerel, Remi Neviere, Eugenie Delile, et al.
Environmental Pollution (Barking, Essex : 1987)|December 25, 2018
An integrated functional and transcriptomic analysis reveals that repeated exposure to diesel exhaust induces sustained mitochondrial and cardiac dysfunctionsAhmed Karoui, Clément Crochemore, Paul Mulder, et al.
Journal of Molecular and Cellular Cardiology|March 27, 2012
Reduction of heart failure by pharmacological inhibition or gene deletion of protein tyrosine phosphatase 1BElodie Gomez, Magali Vercauteren, Baptiste Kurtz, et al.
JACC. Basic to Translational Science|August 1, 2018
The IL-1β Antibody Gevokizumab Limits Cardiac Remodeling and Coronary Dysfunction in Rats With Heart FailureNajah Harouki, Lionel Nicol, Isabelle Remy-Jouet, et al.
Circulation|March 3, 2016
Selective Stimulation of Cardiac Lymphangiogenesis Reduces Myocardial Edema and Fibrosis Leading to Improved Cardiac Function Following Myocardial InfarctionOrianne Henri, Chris Pouehe, Mahmoud Houssari, et al.
Circulation|August 10, 2011
Arteriogenic therapy by intramyocardial sustained delivery of a novel growth factor combination prevents chronic heart failureSébastien Banquet, Elodie Gomez, Lionel Nicol, et al.
Bipolar Disorders|February 16, 2011
Long-term outcome of bipolar depressed patients receiving lamotrigine as add-on to lithium with the possibility of the addition of paroxetine in nonresponders: a randomized, placebo-controlled trial with a novel designMarc L M van der Loos, Paul Mulder, Erwin G Th M Hartong, et al.
Pageof 12

Showing results (91-100 of 116) with videos related to

Sort By:
Pageof 12
Scientific Reports|December 1, 2018
Publisher Correction: MicroRNAs regulating superoxide dismutase 2 are new circulating biomarkers of heart failureEmilie Dubois-Deruy, Marie Cuvelliez, Jan Fiedler, et al.
Scientific Reports|November 9, 2017
MicroRNAs regulating superoxide dismutase 2 are new circulating biomarkers of heart failureEmilie Dubois-Deruy, Marie Cuvelliez, Jan Fiedler, et al.
Scientific Reports|January 29, 2021
Antifibrotic effect of novel neutrophil gelatinase-associated lipocalin inhibitors in cardiac and renal disease modelsBenjamin Bonnard, Ernesto Martínez-Martínez, Amaya Fernández-Celis, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 1, 2014
Gene deletion of protein tyrosine phosphatase 1B protects against sepsis-induced cardiovascular dysfunction and mortalityDavid Coquerel, Remi Neviere, Eugenie Delile, et al.
Environmental Pollution (Barking, Essex : 1987)|December 25, 2018
An integrated functional and transcriptomic analysis reveals that repeated exposure to diesel exhaust induces sustained mitochondrial and cardiac dysfunctionsAhmed Karoui, Clément Crochemore, Paul Mulder, et al.
Journal of Molecular and Cellular Cardiology|March 27, 2012
Reduction of heart failure by pharmacological inhibition or gene deletion of protein tyrosine phosphatase 1BElodie Gomez, Magali Vercauteren, Baptiste Kurtz, et al.
JACC. Basic to Translational Science|August 1, 2018
The IL-1β Antibody Gevokizumab Limits Cardiac Remodeling and Coronary Dysfunction in Rats With Heart FailureNajah Harouki, Lionel Nicol, Isabelle Remy-Jouet, et al.
Circulation|March 3, 2016
Selective Stimulation of Cardiac Lymphangiogenesis Reduces Myocardial Edema and Fibrosis Leading to Improved Cardiac Function Following Myocardial InfarctionOrianne Henri, Chris Pouehe, Mahmoud Houssari, et al.
Circulation|August 10, 2011
Arteriogenic therapy by intramyocardial sustained delivery of a novel growth factor combination prevents chronic heart failureSébastien Banquet, Elodie Gomez, Lionel Nicol, et al.
Bipolar Disorders|February 16, 2011
Long-term outcome of bipolar depressed patients receiving lamotrigine as add-on to lithium with the possibility of the addition of paroxetine in nonresponders: a randomized, placebo-controlled trial with a novel designMarc L M van der Loos, Paul Mulder, Erwin G Th M Hartong, et al.
Pageof 12